Immune checkpoint inhibitor–associated myocarditis : Case reports and a review of the literature
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1876-6250
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Immune checkpoint inhibitor–associated myocarditis ; day:21 ; month:1 ; year:2022 ; pages:1-7
Netherlands heart journal ; (21.1.2022), 1-7
- Urheber
-
Osinga, T. E.
Oosting, S. F.
Meer, P. van der
Boer, R. A. de
Kuenen, B. C.
Rutgers, A.
Bergmann, L.
Oude Munnink, T. H.
Jalving, M.
Kruchten, M. van
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12471-021-01655-7
- URN
-
urn:nbn:de:101:1-2022050221584792965789
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Osinga, T. E.
- Oosting, S. F.
- Meer, P. van der
- Boer, R. A. de
- Kuenen, B. C.
- Rutgers, A.
- Bergmann, L.
- Oude Munnink, T. H.
- Jalving, M.
- Kruchten, M. van
- SpringerLink (Online service)
Ähnliche Objekte (12)
ANGPTL2 promotes immune checkpoint inhibitor-related murine autoimmune myocarditis
Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors
Smoldering myocarditis following immune checkpoint blockade
Clinical and pathological characteristics of immune checkpoint inhibitor-related fulminant myocarditis
Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature
Refractory right ventricular myocarditis induced by immune checkpoint inhibitor despite therapy cessation and immune suppression
Treatment of corticosteroid refractory immune checkpoint inhibitor myocarditis with Infliximab: a case series
Steroid-Refractory Myocarditis Induced by Immune Checkpoint Inhibitor Responded to Infliximab: Report of Two Cases and Literature Review
Reconstitution of peripheral blood T cell receptor β immune repertoire in immune checkpoint inhibitors associated myocarditis
Clinicopathological classification of immune checkpoint inhibitor-associated myocarditis: possible refinement by measuring macrophage abundance
Complete heart block is a significant predictor of mortality in immune checkpoint inhibitor myocarditis
A case of subclinical immune checkpoint inhibitor-associated myocarditis in non-small cell lung cancer
ANGPTL2 promotes immune checkpoint inhibitor-related murine autoimmune myocarditis
Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors
Smoldering myocarditis following immune checkpoint blockade
Clinical and pathological characteristics of immune checkpoint inhibitor-related fulminant myocarditis
Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature
Refractory right ventricular myocarditis induced by immune checkpoint inhibitor despite therapy cessation and immune suppression
Treatment of corticosteroid refractory immune checkpoint inhibitor myocarditis with Infliximab: a case series
Steroid-Refractory Myocarditis Induced by Immune Checkpoint Inhibitor Responded to Infliximab: Report of Two Cases and Literature Review
Reconstitution of peripheral blood T cell receptor β immune repertoire in immune checkpoint inhibitors associated myocarditis
Clinicopathological classification of immune checkpoint inhibitor-associated myocarditis: possible refinement by measuring macrophage abundance
Complete heart block is a significant predictor of mortality in immune checkpoint inhibitor myocarditis
A case of subclinical immune checkpoint inhibitor-associated myocarditis in non-small cell lung cancer
ANGPTL2 promotes immune checkpoint inhibitor-related murine autoimmune myocarditis
Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors
Smoldering myocarditis following immune checkpoint blockade
Clinical and pathological characteristics of immune checkpoint inhibitor-related fulminant myocarditis
Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature
Refractory right ventricular myocarditis induced by immune checkpoint inhibitor despite therapy cessation and immune suppression
Treatment of corticosteroid refractory immune checkpoint inhibitor myocarditis with Infliximab: a case series
Steroid-Refractory Myocarditis Induced by Immune Checkpoint Inhibitor Responded to Infliximab: Report of Two Cases and Literature Review
Reconstitution of peripheral blood T cell receptor β immune repertoire in immune checkpoint inhibitors associated myocarditis
Clinicopathological classification of immune checkpoint inhibitor-associated myocarditis: possible refinement by measuring macrophage abundance
Complete heart block is a significant predictor of mortality in immune checkpoint inhibitor myocarditis